Renal involvement and the role of Notch signalling in Alagille syndrome

Nature Reviews Nephrology

Volumn 9, Issue 7, 2013, Pages 409-418

  Kamath, Binita M ^a   Spinner, Nancy B ^b   Rosenblum, Norman D ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; JAGGED1; NOTCH RECEPTOR; TRIACYLGLYCEROL;

ALAGILLE SYNDROME; AWARENESS; CELL DIFFERENTIATION; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; END STAGE LIVER DISEASE; ENDOTHELIUM CELL; FALLOT TETRALOGY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HAJDU CHENEY SYNDROME; HISTOPATHOLOGY; HUMAN; HYPERCHLOREMIC ACIDOSIS; KIDNEY BIOPSY; KIDNEY COLLECTING TUBULE; KIDNEY DEVELOPMENT; KIDNEY DYSPLASIA; KIDNEY FAILURE; KIDNEY TUBULE ACIDOSIS; LIPIDOSIS; METABOLIC ACIDOSIS; NEPHROLOGIST; NEPHRON; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RENOVASCULAR HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; XANTHOMA;

ALAGILLE SYNDROME; CALCIUM-BINDING PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY DISEASES; MEMBRANE PROTEINS; RECEPTOR, NOTCH2; SIGNAL TRANSDUCTION;

EID: 84879794922     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2013.102     Document Type: Review

References (75)

1. Alagille, D. et al. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J. Pediatr. 2, 195-200 (1987). (Pubitemid 17016845)
2. Crosnier, C., Lykavieris, P., Meunier-Rotival, M. & Hadchouel, M. Alagille syndrome. The widening spectrum of arteriohepatic dysplasia. Clin. Liver Dis. 4, 765-778 (2000).
3. Kamath, B. M., Bason, L., Piccoli, D. A., Krantz, I. D. & Spinner, N. B. Consequences of JAG1 mutations. J. Med. Genet. 40, 891-895 (2003). (Pubitemid 38117538)
4. Emerick, K. M. et al. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology 29, 822-829 (1999). (Pubitemid 29109597)
5. Kamath, B. M. et al. Renal anomalies in Alagille syndrome. Am. J. Med. Genet. 1, 185-189 (2012).
6. Kamath, B. M. et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 109, 1354-1358 (2004). (Pubitemid 38387820)
7. Danks D. M. et al. Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch. Dis. Child. 5, 360-367 (1977). (Pubitemid 8101379)
8. Bauer, R. C. et al. Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. Hum. Mutat. 31, 594-601 (2010).
9. Harendza, S. et al. Renal failure and hypertension in Alagille syndrome with a novel JAG1 mutation. J. Nephrol 18, 312-317 (2005). (Pubitemid 41078952)
10. Jacquet, A. et al. Alagille syndrome in adult patients: it is never too late. Am. J. Kidney Dis. 49, 705-709 (2007). (Pubitemid 46667193)
11. Li, L. et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 16, 243-251 (1997).
12. McDaniell, R. et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 79, 169-173 (2006). (Pubitemid 43927389)
13. Oda, T. et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat. Genet. 16, 235-242 (1997).
14. Warthen, D. M. et al. Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Hum. Mutat. 27, 436-443 (2006). (Pubitemid 43673330)
15. Kamath, B. M., Loomes, K. M. & Piccoli, D. A. Medical management of Alagille syndrome. Pediatr. Gastroenterol. Nutr. 6, 580-586 (2010).
16. Emerick, K. M. & Whitington, P.F. Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome. Hepatology 6, 1501-1506 (2002). (Pubitemid 34966905)
17. Kamath, B. M., Schwarz, K. B. & Hadzic, N. Alagille syndrome and liver transplantation. J. Pediatr. Gastroenterol. Nutr. 50, 11-15 (2010).
18. McElhinney, D. B. et al. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 106, 2567-2574 (2002). (Pubitemid 35340693)
19. Emerick, K. M. et al. Intracranial vascular abnormalities in patients with Alagille syndrome. J. Pediatr. Gastroenterol. Nutr. 41, 99-107 (2005). (Pubitemid 40967363)
20. Bales, C. B. et al. Pathologic lower extremity fractures in children with Alagille syndrome. J. Pediatr. Gastroenterol. Nutr. 51, 66-70 (2010).
21. Kamath, B. M. et al. Facial features in Alagille syndrome: specific or cholestasis facies? Am. J. Med. Genet. 112, 163-170 (2002). (Pubitemid 35332181)
22. Rennie, C. A. et al. The prevalence and associated features of posterior embryotoxon in the general ophthalmic clinic. Eye (Lond.) 19, 396-399 (2005). (Pubitemid 40553139)
23. Benoit, G. et al. Mesangiolipidosis in Alagille syndrome-relationship with apolipoprotein A-I. Nephrol. Dial. Transplant. 22, 2072-2075 (2007). (Pubitemid 47248468)
24. Berard, E. et al. Renovascular hypertension and vascular anomalies in Alagille syndrome. Pediatr. Nephrol. 12, 121-124 (1998). (Pubitemid 28165800)
25. Bourdeaut, F. et al. Alagille syndrome and nephroblastoma: unusual coincidence of two rare disorders. Pediatr. Blood Cancer 50, 908-911 (2008). (Pubitemid 351354819)
26. Chung-Park, M. et al. Renal lipidosis associated with arteriohepatic dysplasia (Alagille's syndrome). Clin. Nephrol. 18, 314-320 (1982). (Pubitemid 13202010)
27. Davis, J., Griffiths, R., Larkin, K., Rozansky, D. & Troxell, M. Glomerular basement membrane lipidosis in Alagille syndrome. Pediatr. Nephrol. 25, 1181-1184 (2010).
28. Devriendt, K. et al. Paucity of intrahepatic bile ducts, solitary kidney and atrophic pancreas with diabetes mellitus: atypical Alagille syndrome? Eur. J. Pediatr. 155, 87-90 (1996). (Pubitemid 26045213)
29. Hirai, H. et al. Successful stenting for renal artery stenosis in a patient with Alagille syndrome. Pediatr. Nephrol. 20, 831-833 (2005). (Pubitemid 40663175)
30. Martin, S. R., Garel, L. & Alvarez, F. Alagille's syndrome associated with cystic renal disease. Arch. Dis. Child. 74, 232-235 (1996). (Pubitemid 26093819)
31. Pombo, F., Isla, C., Gayol, A. & Bargiela, A. Aortic calcification and renal cysts demonstrated by CT in a teenager with Alagille syndrome. Pediatr. Radiol. 25, 314-315 (1995).
32. Quiros-Tejeira, R. E. et al. Variable morbidity in alagille syndrome: a review of 43 cases. J. Pediatr. Gastroenterol. Nutr. 29, 431-437 (1999). (Pubitemid 30346363)
33. Salem, J. E., Bruguiere, E., Iserin, L., Guiochon-Mantel, A. & Plouin, P. F. Hypertension and aortorenal disease in Alagille syndrome. J. Hypertens. 30, 1300-1306 (2012).
34. Schonck, M., Hoorntje, S. & van Hooff, J. Renal transplantation in Alagille syndrome. Nephrol. Dial. Transplant. 13, 197-199 (1998). (Pubitemid 28033605)
35. Schwarzenberg, S. J., Grothe, R. M., Sharp, H. L., Snover, D. C. & Freese, D. Long-term complications of arteriohepatic dysplasia. Am. J. Med. 93, 171-176 (1992).
36. Shrivastava, R. et al. An unusual cause of hypertension and renal failure: a case series of a family with Alagille syndrome. Nephrol. Dial. Transplant. 25, 1501-1506 (2010).
37. Subramaniam, P. et al. Diagnosis of Alagille syndrome-25 years of experience at King's College Hospital. J. Pediatr. Gastroenterol. Nutr. 52, 84-89 (2011).
38. Tolia, V., Dubois, R. S., Watts, F. B., Jr & Perrin, E. Renal abnormalities in paucity of interlobular bile ducts. J. Pediatr. Gastroenterol. Nutr. 6, 971-976 (1987). (Pubitemid 18046928)
39. Wang, J. S. et al. Clinical and pathological characteristics of Alagille syndrome in Chinese children. World J. Pediatr. 4, 283-288 (2008).
40. Wolfish, N. M. & Shanon, A. Nephropathy in arteriohepatic dysplasia (Alagille's syndrome). Child. Nephrol. Urol. 9, 169-172 (1988). (Pubitemid 19171074)
41. Yucel, H., Hoorntje, S. J. & Bravenboer, B. Renal abnormalities in a family with Alagille syndrome. Neth. J. Med. 68, 38-39 (2010).
42. Habib, R. et al. Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia). Pediatr. Nephrol. 1, 455-464 (1987). (Pubitemid 18016646)
43. Kamath, B. M. et al. Outcomes of liver transplantation for patients with Alagille syndrome: the studies of pediatric liver transplantation experience. Liver Transpl. 8, 940-948 (2012).
44. Kamath, B. M. et al. Facial features in Alagille syndrome: specific or cholestasis facies? Am. J. Med. Genet. 112, 163-170 (2002). (Pubitemid 35332181)
45. Crosnier, C. et al. Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome. Gastroenterology 116, 1141-1148 (1999). (Pubitemid 29203024)
46. Spinner, N. B. et al. Jagged1 mutations in Alagille syndrome. Hum. Mutat. 17, 18-33 (2001). (Pubitemid 32051872)
47. Yerushalmi, B., Sokol, R. J., Narkewicz, M. R., Smith, D. & Karrer, F. M. Use of rifampin for severe pruritus in children with chronic cholestasis. J. Pediatr. Gastroenterol. Nutr. 29, 442-447 (1999). (Pubitemid 30346365)
48. Kamath, B. M. et al. NOTCH2 mutations in Alagille syndrome. J. Med. Genet. 2, 138-144 (2012).
49. Isidor, B. et al. Serpentine fibula-polycystic kidney syndrome caused by truncating mutations in NOTCH2. Hum. Mutat. 32, 1239-1242 (2011).
50. Simpson, M. A. et al. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat. Genet. 43, 303-305 (2011).
51. Gray, M. J. et al. Serpentine fibula polycystic kidney syndrome is part of the phenotypic spectrum of Hajdu-Cheney syndrome. Eur. J. Hum. Genet. 20, 122-124 (2012).
52. Gridley, T. Notch signaling during vascular development. Proc. Natl Acad. Sci. USA 98, 5377-5378 (2001). (Pubitemid 32435650)
53. Kopan, R. Notch signaling. Cold Spring Harb. Perspect. Biol. 4, 1-4 (2012).
54. Crosnier, C. et al. JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome. Hepatology 32, 574-581 (2000).
55. McCright, B., Lozier, J. & Gridley, T. A mouse model of Alagille syndrome: notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 129, 1075-1082 (2002). (Pubitemid 34874130)
56. McCright, B. Notch signaling in kidney development. Curr. Opin. Nephrol. Hypertens. 12, 5-10 (2003). (Pubitemid 36092308)
57. Sirin, Y. & Susztak, K. Notch in the kidney: development and disease. J. Pathol. 226, 394-403 (2012).
58. Cheng, H. T. & Kopan, R. The role of Notch signaling in specification of podocyte and proximal tubules within the developing mouse kidney. Kidney Int. 68, 1951-1952 (2005). (Pubitemid 43117769)
59. McCright, B. et al. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 128, 491-502 (2001). (Pubitemid 32229592)
60. Weinmaster, G., Roberts, V. J. & Lemke, G. Notch2: a second mammalian Notch gene. Development 116, 931-941 (1992). (Pubitemid 23042434)
61. Cheng, H. T. et al. Gamma-secretase activity is dispensable for mesenchyme-to-epithelium transition but required for podocyte and proximal tubule formation in developing mouse kidney. Development 130, 5031-5042 (2003).
62. Krebs, L. T. et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14, 1343-1352 (2000). (Pubitemid 30397078)
63. Uyttendaele, H., Ho, J., Rossant, J. & Kitajewski, J. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc. Natl Acad. Sci. USA 98, 5643-5648 (2001). (Pubitemid 32435695)
64. Xue, Y. et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 8, 723-730 (1999). (Pubitemid 29189039)
65. Cheng, H. T. et al. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 134, 801-811 (2007).
66. Bonegio, R. G., Beck, L. H., Kahlon, R. K., Lu, W. & Salant, D. J. The fate of Notch-deficient nephrogenic progenitor cells during metanephric kidney development. Kidney Int. 79, 1099-1112 (2011).
67. Fujimura, S., Jiang, Q., Kobayashi, C. & Nishinakamura, R. Notch2 activation in the embryonic kidney depletes nephron progenitors. J. Am. Soc. Nephrol. 21, 803-810 (2010).
68. Si-Tayeb, K., Lemaigre F. P. & Duncan, S. Organogenesis and development of the liver. Development 18, 175-189 (2010).
69. Kodama, Y., Hijikata, M., Kageyama, R., Shimotohno, K. & Chiba, T. The role of Notch signaling in the development of intrahepatic bile ducts. Gastroenterology 127, 1775-1786 (2004). (Pubitemid 39575856)
70. Hofmann, J. J. et al. Jagged in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome. Development 137, 4061-4072 (2010).
71. Walsh, D. W. et al. Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Biochim. Biophys. Acta 1782, 10-21 (2008).
72. Murea, M. et al. Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis and renal function. Kidney Int. 78, 514-522 (2010).
73. Kobayashi, T. et al. Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int. 73, 1240-1250 (2008). (Pubitemid 351693161)
74. Oestrich, A. E., Sokol, R. J., Suchy, F. J. & Heubi, J. E. Renal abnormalities in arteriohepatic dysplasia and nonsyndromic intrahepatic biliary hypoplasia. Ann. Radiol. (Paris) 26, 203-209 (1983). (Pubitemid 13052688)
75. Hyams, J. S., Berman, M. M & Davis, B. H. Tubulointerstitial nephropathy associated with arteriohepatic dysplasia. Gastroenterology 85, 430-434 (1983). (Pubitemid 13070932)